February 2012

Luis Serrano: “Modify the concentration of a protein, an epigenetic change, may result in disease”

The director of the Center for Genomic Regulation (CRG) in Barcelona, Luis Serrano, explained the latest developments of his research group on Systems Biology in a conference of the series of seminars IDIBELL on February 24. One of the highlights of the Serrano team is to study proteins, not as single molecules, but as parts […]

Luis Serrano: “Modify the concentration of a protein, an epigenetic change, may result in disease” Read More »

Pablo Meyer: ”The distribution of enzymes in the cell is like a mirror of its metabolic status”

The researcher of the Thomas J. Watson Research Center, IBM Research in New York, Pablo Meyer, explained in a special seminar on 16 February his research on the regulation of cellular metabolism based on the distribution of enzymes and mitochondria in the cytoplasm. Meyer and his team have shown in E.coli that the location and

Pablo Meyer: ”The distribution of enzymes in the cell is like a mirror of its metabolic status” Read More »

IDIBELL researchers take a step forwards in transplanting pig cells to regenerate human cartilage

The research group New Therapies on Genes and Transplantation at the IDIBELL first studied the response of human NK cells (Natural Killer) against porcine chondrocytes (cartilage cells). The results of the research, published in The Journal of Immunology, indicate that these cells, characteristic of the innate immune system play an important role in the rejection

IDIBELL researchers take a step forwards in transplanting pig cells to regenerate human cartilage Read More »

José María Aguado: ”Our goal is to customize the treatment for CMV in transplant patients”

Factors influencing Citomeglaovirus infection (CMV) and how to prevent it focused the conference of the researcher at the Institute for Biomedical Research Hospital Universitario 12 de Octubre in Madrid, Jose Maria Aguado, in IDIBELL seminar series on 17 February. CMV is an herpes virus that affects the vast majority of patients with solid organ transplantation.

José María Aguado: ”Our goal is to customize the treatment for CMV in transplant patients” Read More »

Newspaper El Mundo ranks Manel Esteller as one of the 25 top health professionals of 2011

The Newpaper El Mundo ranks the IDIBELL researcher Manel Esteller as one of the most influent health professionals in Spain of 2011. Other relevant personalities of the ranking are Joan Rodés, Josep Baselga and Anna Veiga. Manel Esteller is the Director of the Cancer Epigenetics and Biology program of IDIBELL, ICREA (Catalan Institute for Research

Newspaper El Mundo ranks Manel Esteller as one of the 25 top health professionals of 2011 Read More »

IDIBELL participates in a workshop on Rett Syndrome

On Saturday February 18 the second Workshop on Rett syndrome will be held. The event is organized by the Teknon Foundation and the Catalan Association of Rett syndrome. The IDIBELL researcher Manel Esteller will take part in the seminar. The event will be followed on live via IDIBELL website and it will be possible to

IDIBELL participates in a workshop on Rett Syndrome Read More »

Montserrat Baiget: “Medicine will be genomic or it won’t be”

The director of the genetics service at the Hospital de Sant Pau, Montserrat Baiget, explained the latest developments of her research group in pharmacogenetics. It was on February 10 under the IDIBELL seminar series. Starting from the premise that the future of medicine and new therapies involve applying genomics, the group led by Montserrat Baiget

Montserrat Baiget: “Medicine will be genomic or it won’t be” Read More »

What causes language switching in bilinguals?

The proficiency that a bilingual person has of both languages, the context in which he speaks them or unconscious changes in their use are the factors that make people who speak Spanish and Catalan switch from one language to another. The group of Cognition and Brain Plasticity at the Bellvitge Biomedical Research Institute (IDIBELL), led

What causes language switching in bilinguals? Read More »

Jesús García-Foncillas: “Only one in ten ‘first in human’ trials works, but we have to keep trying”

The researcher Jesus Garcia Foncillas has recently joined the Institute of Health Research ‘Fundación Jiménez Díaz’ as director of the Cancer Research Unit. There he continues his research in the field of microRNA, how they control the expression of genes and how they can be useful in clinic. He explained his progress in the seminar

Jesús García-Foncillas: “Only one in ten ‘first in human’ trials works, but we have to keep trying” Read More »

Scroll to Top